• Facebook
  • Twitter
x

RealTime Images

  • Portfolio
  • About
  • Contact
  • Video
  • Blog
  • Archive
Show Navigation
Cart Lightbox Client Area

Search Results

Refine Search
Match all words
Match any word
Prints
Personal Use
Royalty-Free
Rights-Managed
(leave unchecked to
search all images)
Next
{ 268 images found }
twitterlinkedinfacebook

Loading ()...

  • Scientists and technicians involved in the research, development and manufacture of Corona Virus Testing Kits in a laboratory facility near Cape Town, Western Cape, South Africa, RSA
    JMMsonya7r3-05162020.jpg
  • Scientists and technicians involved in the research, development and manufacture of Corona Virus Testing Kits in a laboratory facility near Cape Town, Western Cape, South Africa, RSA
    JMMsonya7r3-06982020.jpg
  • Scientists and technicians involved in the research, development and manufacture of Corona Virus Testing Kits in a laboratory facility near Cape Town, Western Cape, South Africa, RSA
    JMMsonya7r3-06682020.jpg
  • Scientists and technicians involved in the research, development and manufacture of Corona Virus Testing Kits in a laboratory facility near Cape Town, Western Cape, South Africa, RSA
    JMMsonya7r3-06482020.jpg
  • Scientists and technicians involved in the research, development and manufacture of Corona Virus Testing Kits in a laboratory facility near Cape Town, Western Cape, South Africa, RSA
    JMMsonya7r3-06362020.jpg
  • Scientists and technicians involved in the research, development and manufacture of Corona Virus Testing Kits in a laboratory facility near Cape Town, Western Cape, South Africa, RSA
    JMMsonya7r3-05532020.jpg
  • Scientists and technicians involved in the research, development and manufacture of Corona Virus Testing Kits in a laboratory facility near Cape Town, Western Cape, South Africa, RSA
    JMMsonya7r3-05612020.jpg
  • Scientists and technicians involved in the research, development and manufacture of Corona Virus Testing Kits in a laboratory facility near Cape Town, Western Cape, South Africa, RSA
    JMMsonya7r3-04472020.jpg
  • Scientists and technicians involved in the research, development and manufacture of Corona Virus Testing Kits in a laboratory facility near Cape Town, Western Cape, South Africa, RSA
    JMMsonya7r3-04892020.jpg
  • Scientists and technicians involved in the research, development and manufacture of Corona Virus Testing Kits in a laboratory facility near Cape Town, Western Cape, South Africa, RSA
    JMMsonya7r3-05732020.jpg
  • Scientists and technicians involved in the research, development and manufacture of Corona Virus Testing Kits in a laboratory facility near Cape Town, Western Cape, South Africa, RSA
    JMMsonya7r3-05062020.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_095.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_082.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_079.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_093.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_092.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_090.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_089.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_086.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_084.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_083.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_076.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_070.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_069.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_063.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_062.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_061.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_059.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_056.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_055.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_051.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_047.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_044.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_043.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_042.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_041.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_040.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_035.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_034.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_032.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_029.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_026.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_025.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_023.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_016.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_015.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_012.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_011.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_008.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_007.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_005.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_004.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_098.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_097.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_096.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_094.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_091.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_088.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_087.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_081.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_080.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_078.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_077.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_074.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_073.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_072.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_071.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_068.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_067.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_066.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_065.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_064.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_060.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_058.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_057.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_053.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_052.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_050.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_049.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_048.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_046.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_045.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_039.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_038.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_037.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_036.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_033.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_031.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_030.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_028.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_027.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_024.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_022.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_021.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_019.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_018.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_017.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_013.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_010.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_009.jpg
Next